Pathstone Holdings’s Astrana Health ASTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$276K Buy
+5,957
New +$214K ﹤0.01% 2109
2025
Q4
Sell
-16,736
Closed -$474K 2416
2025
Q3
$474K Buy
16,736
+5,449
+48% +$148K ﹤0.01% 1801
2025
Q2
$281K Sell
11,287
-1,866
-14% -$52.6K ﹤0.01% 1946
2025
Q1
$408K Buy
13,153
+3,649
+38% +$122K ﹤0.01% 1806
2024
Q4
$300K Buy
9,504
+3,318
+54% +$158K ﹤0.01% 1968
2024
Q3
$358K Buy
+6,186
New +$304K ﹤0.01% 1897

Other funds holding ASTH

Pathstone Holdings's ASTH Position: Q2 2026 in Review

Pathstone Holdings opened a new position in Astrana Health (ASTH) in Q2 2026: 5,957 shares worth $276K. The stake represents ﹤0.01% of the portfolio and ranks #2109 among its holdings. This is a return to the name: Pathstone Holdings previously reported a position in ASTH as recently as Q3 2025.

Pathstone Holdings first reported a position in ASTH in Q3 2024 and has held it in 6 quarters since. The position peaked at $474K in Q3 2025. 210 funds tracked by Wall St. Rank hold ASTH as of Q2 2026.

  • Pathstone Holdings held 5,957 shares of Astrana Health worth $276K as of Q2 2026.
  • Astrana Health was a new Pathstone Holdings position in Q2 2026.
  • Astrana Health made up ﹤0.01% of Pathstone Holdings's portfolio in Q2 2026, its #2109 holding.
  • Pathstone Holdings first reported a position in Astrana Health in Q3 2024 and has held it in 6 quarters since.
  • Pathstone Holdings's Astrana Health position peaked at $474K in Q3 2025.
  • 210 funds tracked by Wall St. Rank held Astrana Health as of Q2 2026.

Based on Pathstone Holdings's 13F filing for Q2 2026, filed 13 Aug 2026.